Search results
Showing 4261 to 4275 of 8929 results
Evidence-based recommendations on endoscopic radiofrequency ablation for Barrett’s oesophagus with low-grade dysplasia or no dysplasia. This involves using radiofrequency (heat) energy to destroy the abnormal cells and promote the growth of healthy normal cells.
Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care (HTG607)
Evidence-based recommendations on Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care.
Evidence-based recommendations on Alpha-Stim AID for managing anxiety disorders.
Home Events...
Read NICE's statement on modern slavery and human trafficking.
We support the wellbeing of our staff in a number of ways including an employee assistance programme, mental health first aiders and a variety of health and wellbeing activities.
We want people from all walks of life to contribute to our work and share their experience, expertise and passion.
Home Get involved People and communities - putting you at the heart of our work {"@context":"http://schema.org","@type":"BreadcrumbList","itemLis
Membership details, terms of reference, future meeting dates and past meeting minutes for our diagnostics advisory committee.
Supporting the health and care system to implement virtual wards
Virtual wards (also known as hospital at home) provide hospital level care at home.
Mapping NICE guidelines to the CQC's single assessment framework
This NICE resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
See a complete list of all our guidance and quality standards currently open for consultation
Find out what guidance is being considered for development
Epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancer (HTG714)
Evidence-based recommendations on epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancer. This involves radioactive paste being spread on foil over the top of the cancer, to destroy the cancer cells.
View recommendations for HTG714Show all sections
This indicator covers the percentage of patients with a new diagnosis of hypertension in the preceding 1 April to 31 March who have a record of a 12-lead ECG performed in the 3 months before or after the date of entry to the hypertension register. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM77